SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-13-002034
Filing Date
2013-05-15
Accepted
2013-05-15 09:31:12
Documents
18
Period of Report
2013-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_051513.htm 8-K 26803
2 EXHIBIT 99.1 exh_991.htm EX-99.1 31613
3 EXHIBIT 99.2 exh_992.htm EX-99.2 13829
4 exh992_1.jpg GRAPHIC 104634
5 exh992_2.jpg GRAPHIC 210565
6 exh992_3.jpg GRAPHIC 110685
7 exh992_4.jpg GRAPHIC 132079
8 exh992_5.jpg GRAPHIC 215808
9 exh992_6.jpg GRAPHIC 136089
10 exh992_7.jpg GRAPHIC 175385
11 exh992_8.jpg GRAPHIC 138731
12 exh992_9.jpg GRAPHIC 182797
13 exh992_10.jpg GRAPHIC 183901
14 exh992_11.jpg GRAPHIC 207973
15 exh992_12.jpg GRAPHIC 208696
16 exh992_13.jpg GRAPHIC 180157
17 exh992_14.jpg GRAPHIC 160021
18 exh992_15.jpg GRAPHIC 122123
  Complete submission text file 0001171843-13-002034.txt   3477951
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 13844042
SIC: 2834 Pharmaceutical Preparations